Stock Details
PFE is Pfizer Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 50.59$. Average daily volumn in 3 months 25.01M. Market cap 289.47B



Stock symbol : PFE. Exchange : NYSE. Currency : USD
Lastest price : 51.59$. Total volume : 24.34M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Pfizer Inc. (PFE)
Last Price
51.59$
Change
1.50
Volume
24.34M

Previous Close50.09
Open50.65
Day Range50.31-51.70
Bid51.45 x 2.2k
Ask51.53 x 3.1k
Volume24.34M
Average Volume25.01M
Market Cap289.47B
Beta0.71
52 Week Range38.82-61.71
Trailing P/E11.62
Foward P/E0.94
Dividend (Yield %)3.19%
Ex-Dividend Date2022-07-28



Financial Details


According to Pfizer Inc.'s financial reports the company's revenue in 2021 were 81.29B an increase( +97.56%) over the years 2020 revenue that were of 41.65B. In 2021 the company's total earnings were 21.98B while total earnings in 2020 were 9.16B( +133.33%).


Loading ...



Organization

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 trea... tment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Market Cap:
289.47B
Revenue:
81.29B
Total Assets:
181.48B
Total Cash:
1.94B



News about "Pfizer Inc."

pfizer-inc-nysepfe-stock-holdings-increased-by-redpoint-investment-management-pty-ltd-image

Pfizer Inc. (NYSE:PFE) Stock Holdings Increased by Redpoint Investment Management Pty Ltd

Source from : Defense World - 7 hours ago

Redpoint Investment Management Pty Ltd lifted its stake in Pfizer Inc. (NYSE:PFE โ€“ Get Rating) by 9.4% in the first quarter, Holdings Channel.com reports. The firm owned 141,914 shares of the ...See details»


pfizer-inc-nysepfe-shares-sold-by-investors-research-corp-image

Pfizer Inc. (NYSE:PFE) Shares Sold by Investors Research Corp

Source from : Defense World - 9 hours ago

Investors Research Corp lessened its holdings in Pfizer Inc. (NYSE:PFE โ€“ Get Rating) by 1.3% in the first quarter, HoldingsChannel.com reports. The firm owned 22,657 shares of the biopharmaceutical ...See details»


pfizer-sued-for-patent-infringement-over-covid-19-drug-paxlovid-image

Pfizer sued for patent infringement over COVID-19 drug Paxlovid

Source from : Reuters - 3 days ago

Pfizer Inc's blockbuster COVID-19 treatment Paxlovid violates an Enanta Pharmaceuticals Inc patent for its COVID drug still in development, according to a lawsuit filed Tuesday in Boston federal court ...See details»


pfizer-inc-nysepfe-stake-raised-by-meag-munich-ergo-kapitalanlagegesellschaft-mbh-image

Pfizer Inc. (NYSE:PFE) Stake Raised by MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH

Source from : ETF Daily News - 9 hours ago

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH boosted its position in shares of Pfizer Inc. (NYSE:PFE โ€“ Get Rating) by 28.9% in the 1st quarter, according to its most recent filing with the ...See details»


mcia-inc-sells-4122-shares-of-pfizer-inc-nysepfe-image

MCIA Inc Sells 4,122 Shares of Pfizer Inc. (NYSE:PFE)

Source from : ETF Daily News - 1 days ago

MCIA Inc cut its stake in shares of Pfizer Inc. (NYSE:PFE โ€“ Get Rating) by 8.7% in the first quarter, Holdings Channel reports. The firm owned 43,276 shares of the biopharmaceutical companyโ€™s stock ...See details»


pfizer-invites-public-to-view-and-listen-to-webcast-of-july-28-conference-call-with-analysts-image

Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analysts

Source from : YAHOO!Finance - 1 days ago

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Thursday, July 28, 2022. The purpose of ...See details»


Pfizer Declares Third-Quarter 2022 Dividend

Source from : Associated Press - 2 days ago

(NYSE: PFE) today announced that its board of directors declared a $0.40 third-quarter 2022 dividend on the companyโ€™s common ...See details»


70m-immunotherapy-startup-launches-with-backing-from-pfizer-astellas-image

$70M immunotherapy startup launches with backing from Pfizer, Astellas

Source from : The Business Journals - 2 days ago

The venture arms of life sciences giants Pfizer Inc. and Astellas Pharma, plus biotech real estate developer Alexandria Real Estate Equities Inc., are backing a brand-new immunotherapy startup ...See details»


enanta-pharmaceuticals-sues-pfizer-for-patent-infringement-involving-paxlovid-image

Enanta Pharmaceuticals sues Pfizer for patent infringement involving Paxlovid

Source from : The Business Journals - 3 days ago

Watertown biotech Enanta Pharmaceuticals Inc. has sued Pfizer Inc., alleging that the drug giant violated a patent Enanta was awarded earlier this month.See details»


pfizer-stops-enrollment-in-paxlovid-trial-in-standard-risk-population-image

Pfizer stops enrollment in Paxlovid trial in standard-risk population

Source from : Reuters - 10 days ago

Pfizer Inc said on Tuesday it would halt enrollment in a trial for its COVID-19 antiviral drug, Paxlovid, in standard-risk patients after a study revealed the treatment was not effective in reducing ...See details»


Basilea' Partner Pfizer Gets Approval In China For Addl Formulation Of Antifungal Cresemba In China

Source from : Nasdaq - 1 days ago

Pfizer Inc. (PFE), has received a Drug Approval License from the National Medical Products Administration in China, for the intravenous formulation of Cresemba or isavuconazole for the treatment of ...See details»


healthcare-corporations-pfizer-and-unitedhealthcare-are-among-the-biggest-financial-backers-of-lawmakers-behind-state-abortion-bans-image

Healthcare corporations Pfizer and UnitedHealthcare are among the biggest financial backers of lawmakers behind state abortion bans

Source from : Business Insider India on MSN.com - 1 days ago

AbbVie Inc., another company with ties to makers of contraceptives ... experts told The Guardian. Like Pfizer, Bayer and AbbVie have made commitments to diversity, equity, and inclusion in the ...See details»


pfizer-covid-shot-works-safe-for-youngest-kids-fda-says-image

Pfizer Covid Shot Works, Safe for Youngest Kids, FDA Says

Source from : Bloomberg on MSN.com - 12 days ago

US Food and Drug Administration staff said that Pfizer Inc.โ€™s Covid shot was effective for kids ages 4 and under with no new safety concerns, in a report released ahead of a key meeting of FDA ...See details»


pfizer-to-buy-81-percent-stake-in-french-vaccines-company-valneva-image

Pfizer to buy 8.1 percent stake in French vaccines company Valneva

Source from : Nasdaq - 5 days ago

Valneva will use the proceeds from Pfizerโ€™s equity investment to support its Phase 3 development contribution to the Lyme disease program. Valneva and Pfizer also updated the te ...See details»